HOUSE OF COMMONS OF CANADA
35th PARLIAMENT, 2nd SESSION

EVIDENCE

Standing Committee
on

INDUSTRY

Chairman: David Walker, Lib.

Meeting No. 50

Tuesday, March 11, 1997

ORDER OF THE DAY:

Review of Section 14 of the Patent Act Amendment 1992 (Chapter 2, Statutes of Canada, 1993)

WITNESSES:

Astra Pharma Inc.:

Gerald McDole, President and Chief Executive Officer.

BioChem Pharma:

Francesco Bellini, President and CEO.

Genpharm:

Neil Tabatznik, Chairman.

Novartis Pharmaceuticals Canada Inc.:

Hans J. Mäder, President and Chief Executive Officer.

Pfizer Canada Inc.:

Karl Parker, Vice-President, Government and Public Affairs.

Technilab Pharma Inc.:

Jean-Guy Goulet, Senior Vice-President, Business Development.